Growth Metrics

Organogenesis Holdings (ORGO) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Organogenesis Holdings (ORGO) over the last 10 years, with Q3 2025 value amounting to $68.1 million.

  • Organogenesis Holdings' Cash & Current Investments fell 2824.94% to $68.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.1 million, marking a year-over-year decrease of 2824.94%. This contributed to the annual value of $136.2 million for FY2024, which is 3049.03% up from last year.
  • Organogenesis Holdings' Cash & Current Investments amounted to $68.1 million in Q3 2025, which was down 2824.94% from $78.4 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Cash & Current Investments peaked at $136.2 million during Q4 2024, and registered a low of $487000.0 during Q3 2021.
  • Over the past 5 years, Organogenesis Holdings' median Cash & Current Investments value was $94.9 million (recorded in 2024), while the average stood at $84.5 million.
  • Per our database at Business Quant, Organogenesis Holdings' Cash & Current Investments surged by 2208090.35% in 2022 and then plummeted by 2824.94% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Cash & Current Investments stood at $114.5 million in 2021, then decreased by 9.81% to $103.3 million in 2022, then increased by 1.01% to $104.3 million in 2023, then surged by 30.49% to $136.2 million in 2024, then crashed by 49.97% to $68.1 million in 2025.
  • Its last three reported values are $68.1 million in Q3 2025, $78.4 million for Q2 2025, and $117.0 million during Q1 2025.